[613] | 1 | ONCHPC4A ;Hines OIFO/GWB - 2000 Hepatocellular Cancers PCE Study ;01/10/00
|
---|
| 2 | ;;2.11;ONCOLOGY;**26**;Mar 07, 1995
|
---|
| 3 | ;First Course of Treatment (continued)
|
---|
| 4 | R W @IOF D HEAD^ONCHPC0
|
---|
| 5 | W !," RADIATION THERAPY"
|
---|
| 6 | W !," -----------------"
|
---|
| 7 | DRS W !," 44. DATE RADIATION STARTED........: ",$$GET1^DIQ(165.5,IE,51)
|
---|
| 8 | RT W !," 45. RADIATION THERAPY.............: ",$$GET1^DIQ(165.5,IE,51.2)
|
---|
| 9 | W ! K DIR S DIR(0)="E" D ^DIR G:$D(DIRUT) EXIT
|
---|
| 10 | C W @IOF D HEAD^ONCHPC0
|
---|
| 11 | W !," CHEMOTHERAPY"
|
---|
| 12 | W !," ------------"
|
---|
| 13 | DCS W !," 46. DATE CHEMOTHERAPY STARTED.....: ",$$GET1^DIQ(165.5,IE,53)
|
---|
| 14 | CT W !," 47. CHEMOTHERAPY..................: ",$$GET1^DIQ(165.5,IE,53.2)
|
---|
| 15 | TCAA W !!," 48. TYPE OF CHEMOTHERAPEUTIC AGENTS ADMINISTERED:"
|
---|
| 16 | I CHE=0 D G RCA
|
---|
| 17 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,62)=0
|
---|
| 18 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,63)=0
|
---|
| 19 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,64)=0
|
---|
| 20 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,65)=0
|
---|
| 21 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,66)=0
|
---|
| 22 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,67)=0
|
---|
| 23 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,68)=0
|
---|
| 24 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,69)=0
|
---|
| 25 | .W !," CISPLATIN....................: No"
|
---|
| 26 | .W !," FUDR.........................: No"
|
---|
| 27 | .W !," 5-FU.........................: No"
|
---|
| 28 | .W !," FU & LEUCOVORIN..............: No"
|
---|
| 29 | .W !," IRINOTECAN (CPT-11)..........: No"
|
---|
| 30 | .W !," MITOMYCIN C..................: No"
|
---|
| 31 | .W !," OXALIPLATIN..................: No"
|
---|
| 32 | .W !," GEMCITABINE..................: No"
|
---|
| 33 | I CHE=9 D G RCA
|
---|
| 34 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,62)=9
|
---|
| 35 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,63)=9
|
---|
| 36 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,64)=9
|
---|
| 37 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,65)=9
|
---|
| 38 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,66)=9
|
---|
| 39 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,67)=9
|
---|
| 40 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,68)=9
|
---|
| 41 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,69)=9
|
---|
| 42 | .W !," CISPLATIN....................: Unknown if recommended or administered"
|
---|
| 43 | .W !," FUDR.........................: Unknown if recommended or administered"
|
---|
| 44 | .W !," 5-FU.........................: Unknown if recommended or administered"
|
---|
| 45 | .W !," FU & LEUCOVORIN..............: Unknown if recommended or administered"
|
---|
| 46 | .W !," IRINOTECAN (CPT-11)..........: Unknown if recommended or administered"
|
---|
| 47 | .W !," MITOMYCIN C..................: Unknown if recommended or administered"
|
---|
| 48 | .W !," OXALIPLATIN..................: Unknown if recommended or administered"
|
---|
| 49 | .W !," GEMCITABINE..................: Unknown if recommended or administered"
|
---|
| 50 | S DR="1061 CISPLATIN...................." D ^DIE G:$D(Y) JUMP
|
---|
| 51 | S DR="1062 FUDR........................." D ^DIE G:$D(Y) JUMP
|
---|
| 52 | S DR="1063 5-FU........................." D ^DIE G:$D(Y) JUMP
|
---|
| 53 | S DR="1064 FU & LEUCOVORIN.............." D ^DIE G:$D(Y) JUMP
|
---|
| 54 | S DR="1065 IRINOTECAN (CPT-11).........." D ^DIE G:$D(Y) JUMP
|
---|
| 55 | S DR="1066 MITOMYCIN C.................." D ^DIE G:$D(Y) JUMP
|
---|
| 56 | S DR="1067 OXALIPLATIN.................." D ^DIE G:$D(Y) JUMP
|
---|
| 57 | S DR="1068 GEMCITABINE.................." D ^DIE G:$D(Y) JUMP
|
---|
| 58 | RCA W !
|
---|
| 59 | I (CHE=0)!(CHE=9) D G CSS
|
---|
| 60 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,70)=88
|
---|
| 61 | .W !," 49. ROUTE CHEMOTHERAPY ADMIN......: NA"
|
---|
| 62 | S DR="1069 49. ROUTE CHEMOTHERAPY ADMIN" D ^DIE G:$D(Y) JUMP
|
---|
| 63 | CSS I (CDS="00")!(CDS=99)!(CHE=0)!(CHE=9) D G DIR
|
---|
| 64 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,71)=0
|
---|
| 65 | .W !," 50. CHEMOTHERAPY/SURGERY SEQUENCE.: No chemotherapy and/or no surgery"
|
---|
| 66 | S CDSDT=$$GET1^DIQ(165.5,IE,50,"I")
|
---|
| 67 | S CHEDT=$$GET1^DIQ(165.5,IE,53,"I")
|
---|
| 68 | I (CDSDT="")!(CHEDT="") G CSS1
|
---|
| 69 | I CHEDT<CDSDT D G DIR
|
---|
| 70 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,71)=1
|
---|
| 71 | .W !," 50. CHEMOTHERAPY/SURGERY SEQUENCE.: Chemotherapy before surgery"
|
---|
| 72 | I CHEDT>CDSDT D G DIR
|
---|
| 73 | .S $P(^ONCO(165.5,ONCONUM,"HEP1"),U,71)=2
|
---|
| 74 | .W !," 50. CHEMOTHERAPY/SURGERY SEQUENCE.: Chemotherapy after surgery"
|
---|
| 75 | CSS1 S DR="1070 50. CHEMOTHERAPY/SURGERY SEQUENCE." D ^DIE G:$D(Y) JUMP
|
---|
| 76 | DIR K DIR S DIR(0)="E" D ^DIR G:$D(DIRUT) EXIT
|
---|
| 77 | O W @IOF D HEAD^ONCHPC0
|
---|
| 78 | W !," OTHER THERAPY"
|
---|
| 79 | W !," -------------"
|
---|
| 80 | DOTS W !," 51. DATE OTHER TREATMENT STARTED..: ",$$GET1^DIQ(165.5,IE,57)
|
---|
| 81 | OT W !," 52. OTHER TREATMENT...............: ",$$GET1^DIQ(165.5,IE,57.2)
|
---|
| 82 | AE S DR="1071 53. ARTERIAL EMBOLIZATION........." D ^DIE G:$D(Y) JUMP
|
---|
| 83 | DWTD S DR="1072 54. DEATH WITHIN 30 DAYS OF START OF INITIAL COURSE OF THERAPY." D ^DIE G:$D(Y) JUMP
|
---|
| 84 | PRTC W ! K DIR S DIR(0)="E" D ^DIR S:$D(DIRUT) OUT="Y"
|
---|
| 85 | G EXIT
|
---|
| 86 | JUMP ;Jump to prompts
|
---|
| 87 | S XX="" R !!," GO TO ITEM: ",X:DTIME I (X="")!(X[U) S OUT="Y" G EXIT
|
---|
| 88 | I X["?" D G:$D(DIRUT) EXIT G JUMP
|
---|
| 89 | .W @IOF,!," CHOOSE FROM:" F I=1:1:CHOICES W !,?5,HTABLE(I) I I=18 W ! K DIR S DIR(0)="E" D ^DIR Q:$D(DIRUT) W @IOF,!," CHOOSE FROM:"
|
---|
| 90 | I '$D(TABLE(X)) S:X?1.2N X=X_"." S XX=X,X=$O(TABLE(X)) I ($P(X,XX,1)'="")!(X="") W *7,"??" D G JUMP
|
---|
| 91 | .W !," CHOOSE FROM:" F I=1:1:CHOICES W !,?5,HTABLE(I) I I=18 W ! K DIR S DIR(0)="E" D ^DIR Q:$D(DIRUT) W @IOF,!," CHOOSE FROM:"
|
---|
| 92 | S X=TABLE(X)
|
---|
| 93 | G @X
|
---|
| 94 | EXIT S:$D(DIRUT) OUT="Y"
|
---|
| 95 | K CHOICES,PIECE,HTABLE,TABLE
|
---|
| 96 | K CDS,CHE,LOS,NCDS,NOP,RAD,SA,SA1,SA2,SM,SM1,SM2
|
---|
| 97 | K DA,DIE,DIR,DIROUT,DIRUT,DR,DTOUT,DUOUT,X,XX,Y
|
---|
| 98 | Q
|
---|